In cases of familial primary ovarian insufficiency and disorders of gonadal development, consider NR5A1/SF-1 sequence variants. Issue 1 (January 2020)

• Record Type: Journal Article
• Authors: Bertrand-Delepine, Juliette; Manouvrier-hanu, Sylvie; Cartigny, Maryse; Paris, Françoise; Mallet, Delphine; Philibert, Pascal; Morel, Yves; Lefevre, Christine; Dewailly, Didier; Catteau-jonard, Sophie
• Is Part Of: Reproductive biomedicine online. Volume 40:Issue 1(2020)
• Page Start: 151
• Page End: 159
• Publication Date: 2020-01
• Subjects: Disorders of gonadal development -- Hypospadias -- NR5A1/SF-1 sequence variant -- Primary ovarian insufficiency; Human reproductive technology -- Periodicals; Human embryo -- Periodicals; Reproduction -- Periodicals; 616.692
• DOI: 10.1016/j.rbmo.2019.10.002
• Languages: English
• ISSNs: 1472-6483

Abstract

Abstract: Research question: Primary ovarian insufficiency (POI) is defined as the early exhaustion of ovarian function, before the age of 40 years. Its origin is genetic in 20–25% of cases. In rare cases, sequence variants of the NR5A1 /SF-1 gene may result in POI, or in various disorders of gonadal development (DGD) or adrenal insufficiency. Design: This study describes the cases of two families in which the association of DGD and POI enabled a diagnosis of NR5A1 deleterious variations. Their clinical, hormonal, ultrasound and genetic characteristics are reported. Results: The mothers of the affected children were 21 and 29 years when POI was diagnosed. Each nonetheless had two spontaneous pregnancies. The children have different phenotypes and different forms of DGD. None of the affected family members had adrenal insufficiency. A new sequence variant of the NR5A1 gene was identified in one family: p.Cys283Phe (c.848G>T), and the NR5A1 sequence variant c.86G>C was found in the other family. Conclusion: Sequence variation of the NR5A1 gene is a possibility that must be considered when a woman with POI or a diminished ovarian reserve has a family member or child with DGD. If a variant is identified, genetic counselling is essential for the patient and his/her family.